RxNorm Semantic Concepts Index - 286
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "286".
| Concept ID (RxCUI) | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| Concept ID (RxCUI): 28603 | LTA-4 hydrolase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 28603 | LTA-4 hydrolase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 28603 | LTA-4 hydrolase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 28605 | LTB4 omega-hydroxylase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 28605 | LTB4 omega-hydroxylase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 28605 | LTB4 omega-hydroxylase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 28605 | LTB4 omega-hydroxylase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 28613 | Leukotriene E | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 28613 | Leukotriene E | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 28622 | Levanase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 28622 | Levanase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 28624 | Sucrose 6-fructosyltransferase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 28624 | Sucrose 6-fructosyltransferase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 28624 | Sucrose 6-fructosyltransferase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 28627 | levocabastine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 28627 | levocabastine | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 28627 | levocabastine | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 28627 | levocabastine | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 28627 | levocabastine | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 28635 | Repressor lexA | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 28635 | Repressor lexA | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 28656 | Nafarelin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 28656 | Nafarelin | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 28656 | Nafarelin | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 28656 | Nafarelin | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 28656 | Nafarelin | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 28697 | Librax | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 28699 | Lichenase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 28699 | Lichenase | Full form of descriptor (FN) | NO |